Rifabutin use in inflammatory bowel disease.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy; D010865:Pilot Projects; D017828:Rifabutin / Q000009:adverse effects / Q000627:therapeutic use*; D013492:Suppuration / Q000139:chemically induced; D014606:Uveitis, Anterior / Q000139:chemically induced
D000900:Anti-Bacterial Agents; D017828:Rifabutin